ANIK (STOCKS)
Anika Therapeutics Inc
$14.890000
+0.130000 (+0.88%)
Prev close: $14.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stephen D. Griffin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $199.40M
- Employees
- 288
- P/E (TTM)
- -19.45
- P/B (TTM)
- 1.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.02 | $-0.22 | +0.2393 | +109.12% |
|
Sep 2025 (Q3)
|
$-0.16 | $-0.28 | +0.1154 | +41.90% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.26 | -0.0216 | -8.36% |
|
Mar 2025 (Q1)
|
$-0.34 | $-0.15 | -0.1938 | -132.56% |
Financial Statements
| Revenues | $112.82M |
| Benefits Costs and Expenses | $122.13M |
| Cost Of Revenue | $49.01M |
| Costs And Expenses | $74.86M |
| Gross Profit | $63.81M |
| Operating Expenses | $74.86M |
| Selling, General, and Administrative Expenses | $49.09M |
| Depreciation and Amortization | $5.37M |
| Research and Development | $25.77M |
| Operating Income/Loss | -$11.05M |
| Income/Loss From Continuing Operations After Tax | -$9.98M |
| Income/Loss From Continuing Operations Before Tax | -$9.31M |
| Income/Loss From Discontinued Operations Net Of Tax | -$901.00K |
| Income Tax Expense/Benefit | $672.00K |
| Income Tax Expense/Benefit, Current | $611.00K |
| Income Tax Expense/Benefit, Deferred | -$7.00K |
| Net Income/Loss | -$10.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.76 |
| Diluted Earnings Per Share | -$0.76 |
| Basic Average Shares | 14,339,000 |
| Diluted Average Shares | 14,339,000 |
| Assets | $190.27M |
| Current Assets | $103.36M |
| Inventory | $18.79M |
| Other Current Assets | $84.57M |
| Noncurrent Assets | $86.91M |
| Fixed Assets | $40.32M |
| Intangible Assets | $1.65M |
| Other Non-current Assets | $44.94M |
| Liabilities | $46.81M |
| Current Liabilities | $21.91M |
| Accounts Payable | $6.04M |
| Wages | $8.66M |
| Other Current Liabilities | $7.21M |
| Noncurrent Liabilities | $24.90M |
| Equity | $143.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $143.47M |
| Liabilities And Equity | $190.27M |
| Net Cash Flow From Operating Activities | $11.19M |
| Net Cash Flow From Operating Activities, Continuing | $11.19M |
| Net Cash Flow From Investing Activities | -$401.00K |
| Net Cash Flow From Investing Activities, Continuing | -$401.00K |
| Net Cash Flow From Financing Activities | -$10.55M |
| Net Cash Flow From Financing Activities, Continuing | -$10.55M |
| Net Cash Flow | $236.00K |
| Net Cash Flow, Continuing | $236.00K |
| Comprehensive Income/Loss | -$9.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.06M |
| Other Comprehensive Income/Loss | $1.82M |